Details of Investor Call - 15th August 2018
To dial into the call directly, please dial in 5 to 10 minutes prior to the call time and enter the Conference ID: 332129.
Dial in numbers are as follows:
Australian Toll Free: 1800 908 299
New Zealand callers: 0800 452 795
Other callers: +61 2 9007 8048
To pre-register for the call, please follow the link below. A unique pin number will be provided for use when dialling into the call, which will bypass the operator and provide immediate access to the event.
The Investment Proposition – Does the Means Justify the End?
At the 14th Bioshares Biotech Summit, our CEO and MD was asked to address the topic, ‘The Investment Proposition – Does the Means Justify the End?’.
Click the link below to read the summarised presentation.
Quarterly activities & cashflow report quarter ending 30 June 2018
Please click the link to view the report
Presentation at 14th Bioshares Biotech Summit
Click here is see our presentation at the 14th Bioshares Biotech Summit in Queenstown
Company OverviewOver the past decade, LBT Innovations has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefi...
MicroStreakIn its first five years of global sales, LBT’s MicroStreak technology captured the largest share of the international market for automated culture-plate streaking and inoculation. Originally sold by bi...
APASThe Automated Plate Assessment System, or APAS, is a platform technology for the automation of culture-plate screening and interpretation. While LBT’s first product, PREVI Isola, automates the inoculati...